Advertisement
Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conner, C.
Right arrow Articles by Watanabe, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conner, C.
Right arrow Articles by Watanabe, A.
American Journal of Hospital Pharmacy, Vol 36, Issue 7, 906-911
Copyright © 1979 by American Society of Health-System Pharmacists


Articles

Clonidine overdose: a review

CS Conner and AS Watanabe


The pharmacology and pharmacokinetics of clonidine and the symptoms and treatment of acute clinidine overdosage are reviewed. Clonidine, a relatively safe and effective antihypertensive agent when used at therapeutic dosages, reduces blood pressure through a centrally mediated reduction in vasomotor tone. The primary symptoms of clonidine overdosage are central nervous system depression, bradycardia, hypotension, miosis, hypotonia, respiratory depression and possibly seizures. Gastric lavage followed by administration of activated charcoal is used to decrease absorption following acute oral ingestion. Intravenous fluid therapy and dopamine infusion are recommended for severe hypotension, and atropine sulfate is used to manage persistent bradycardia. Treatment of hypotension with alpha-adrenergic blocking agents (e.g., tolazoline) is not recommended unless patients fail to respond to dopamine infusion and administration of i.v. fluids.
 



This article has been cited by other articles:


Home page
Arch Pediatr Adolesc MedHome page
G. P. WEDIN, S. L. RICHARDSON, and G. H. WALLACE
Clonidine Poisoning in Children
Arch Pediatr Adolesc Med, August 1, 1990; 144(8): 853 - 854.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
P. Glue, D. Nutt, and P. Glue
Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medication
J Psychopharmacol, January 1, 1988; 2(3-4): 119 - 137.
[Abstract] [PDF]


Home page
CLIN PEDIATRHome page
J. C. Maggi, M. K. Iskra, and E. Nussbaum
Severe Clonidine Overdose in Children Requiring Critical Care
Clinical Pediatrics, September 1, 1986; 25(9): 453 - 455.
[PDF]


Home page
Arch Pediatr Adolesc MedHome page
M. Artman and R. C. Boerth
Clonidine Poisoning: A Complex Problem
Arch Pediatr Adolesc Med, February 1, 1983; 137(2): 171 - 174.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by the American Society of Health-System Pharmacists.
Advertisement